Gossamer Bio Announces Fourth Quarter and Full-Year 2020 Financial Results and Provides Business Update

Go back to Gossamer Bio Announces Fourth Quarter and Full-Year 2020 Financial Results and Provides Business Update

Gossamer Bio Inc. (GOSS) Reports Q4 Loss of $0.88/sh

February 25, 2021 7:56 AM EST

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q4 EPS of ($0.88), versus ($0.89) reported last year.

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

... More